featured
Sotrovimab Effects on Hospitalization and Death Among High-Risk Patients With Mild to Moderate COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
JAMA 2022 Mar 14;[EPub Ahead of Print], A Gupta, Y Gonzalez-Rojas, E Juarez, M Crespo Casal, J Moya, D Rodrigues Falci, E Sarkis, J Solis, H Zheng, N Scott, AL Cathcart, S Parra, JE Sager, D Austin, A Peppercorn, E Alexander, WW Yeh, C Brinson, M Aldinger, AE ShapiroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.